Codes / ICD10CM / M1A.40X0

M1A.40X0 Other secondary chronic gout, unspecified site, without tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other Secondary Chronic Gout, Unspecified Site, Without Tophus (Tophi)

Summary

Other secondary chronic gout is a form of arthritis resulting from elevated uric acid levels due to an identifiable underlying condition or cause, leading to recurrent joint inflammation. It is characterized by persistent symptoms without the presence of tophi (urate crystal deposits) in the affected site.

Causes

Other secondary chronic gout arises from the body's inability to properly excrete uric acid, which can stem from an underlying condition or factor that disrupts uric acid metabolism or renal clearance. This leads to urate crystal deposition in joints and tissues, triggering inflammation over time.

Risk Factors

  • Underlying conditions that affect uric acid metabolism (e.g., certain hematologic disorders, enzyme deficiencies)
  • Medications that increase uric acid levels (e.g., some diuretics, chemotherapy agents)
  • Chronic kidney disease or renal impairment
  • History of gout or hyperuricemia
  • Exposure to substances that disrupt uric acid excretion

Symptoms

  • Recurrent episodes of intense joint pain, often in the big toe, ankles, or knees
  • Persistent swelling, redness, and warmth in affected joints
  • Stiffness and limited joint mobility
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis detects urate crystals. Imaging may be used to assess joint damage, and the absence of tophi is confirmed during examination.

Treatment Options

Treatment focuses on managing uric acid levels and reducing inflammation. This may include medications to lower uric acid production or increase excretion, anti-inflammatory drugs for acute flare-ups, and lifestyle modifications to address underlying causes.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and joint damage may be minimized. Regular follow-up is important to monitor uric acid levels and adjust treatment as needed to prevent complications.

Complications

Untreated or poorly managed cases may lead to persistent joint damage, chronic pain, and reduced mobility. Recurrent flare-ups can impact quality of life if not addressed.

Lifestyle & Prevention

  • Maintain a balanced diet low in purine-rich foods
  • Stay hydrated to support uric acid excretion
  • Limit alcohol consumption, particularly beer
  • Manage underlying conditions (e.g., kidney disease) with medical guidance
  • Follow prescribed medication regimens consistently

When to Seek Professional Help

Seek medical attention if experiencing severe joint pain, swelling, or redness, especially if symptoms persist or worsen. Prompt evaluation is important to prevent long-term joint damage.

Tips for Medical Coders

This code (M1A.40X0) is used for other secondary chronic gout without tophi in an unspecified site. Documentation should specify the absence of tophi and the underlying cause of secondary gout. Ensure clinical notes support the absence of tophi and the site is not specified to apply this code correctly.

Book a walkthrough

M1A.40X0 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.